237 Aufrufe 237 0 Kommentare 0 Kommentare

    Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries - Seite 2


    As awareness of the increasing prevalence of on-the-job drug use in critical sectors grows, so does the demand for effective drug testing solutions. Intelligent Bio Solutions understands the critical need for robust drug screening processes that can help businesses maintain a safe and productive work environment. Our Intelligent Fingerprinting Drug Screening System is designed to offer a non-invasive, efficient, and reliable method for employers to safeguard their workforce. Considering this growing concern, our growth remains strong, and we are gaining momentum by expanding into new markets and expanding with new accounts.

    We plan to provide additional insights in the coming weeks leading up to the filing of our Annual Report on Form 10-K, along with our upcoming earnings release. For more information about our innovative drug testing solutions and how we can support your organization in maintaining a safe workplace, please contact us or visit our website at www.ibs.inc.

    About Intelligent Bio Solutions Inc.
    Intelligent Bio Solutions Inc. (NASDAQ: INBS) is dedicated to pioneering non-invasive medical technology solutions. Our mission is to deliver innovative, reliable, and user-friendly products that enhance drug testing and screening processes, ultimately contributing to safer and healthier workplaces.

    Forward-Looking Statements:
    Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events. 

    Seite 2 von 3




    globenewswire
    0 Follower
    Autor folgen
    Verfasst von globenewswire
    Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries - Seite 2 NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) - Intelligent Bio Solutions Inc. (NASDAQ: INBS) provides an overview of the increasing prevalence of on-the-job drug use across critical sectors such as construction, manufacturing, transport and …